GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (OTCPK:SMMNY) » Definitions » Cash And Cash Equivalents

Siemens Healthineers AG (Siemens Healthineers AG) Cash And Cash Equivalents : $1,599 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Cash And Cash Equivalents?

Siemens Healthineers AG's quarterly cash and cash equivalents declined from Jun. 2023 ($1,927.41 Mil) to Sep. 2023 ($1,752.40 Mil) but then stayed the same from Sep. 2023 ($1,752.40 Mil) to Dec. 2023 ($1,598.69 Mil).

Siemens Healthineers AG's annual cash and cash equivalents declined from Sep. 2021 ($1,555.29 Mil) to Sep. 2022 ($1,421.78 Mil) but then increased from Sep. 2022 ($1,421.78 Mil) to Sep. 2023 ($1,752.40 Mil).


Siemens Healthineers AG Cash And Cash Equivalents Historical Data

The historical data trend for Siemens Healthineers AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Cash And Cash Equivalents Chart

Siemens Healthineers AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only 1,013.22 772.67 1,555.29 1,421.78 1,752.40

Siemens Healthineers AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,432.20 1,466.81 1,927.41 1,752.40 1,598.69

Siemens Healthineers AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Siemens Healthineers AG  (OTCPK:SMMNY) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Siemens Healthineers AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Siemens Healthineers AG (Siemens Healthineers AG) Business Description

Traded in Other Exchanges
Address
Siemensstr. 3, Forchheim, BY, DEU, 91301
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.